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A natural isolate of Lactococcus lactis was shown to
produce two narrow spectrum class II bacteriocins, des-
ignated LsbA and LsbB. The cognate genes are located
on a 5.6-kb plasmid within a gene cluster specifying
LmrB, an ATP-binding cassette-type multidrug resist-
ance transporter protein. LsbA is a hydrophobic peptide
that is initially synthesized with an N-terminal exten-
sion. The housekeeping surface proteinase HtrA was
shown to be responsible for the cleavage of precursor
peptide to yield the active bacteriocin. LsbB is a rela-
tively hydrophilic protein synthesized without an N-
terminal leader sequence or signal peptide. The secre-
tion of both polypeptides was shown to be mediated by
LmrB. An L. lactis strain lacking plasmid-encoded LmrB
and the chromosomally encoded LmrA is unable to se-
crete either of the two bacteriocins. Complementation of
the strain with an active LmrB protein resulted in re-
stored export of the two polypeptides across the cyto-
plasmic membrane. When expressed in an L. lactis
strain that is sensitive to LsbA and LsbB, LmrB was
shown to confer resistance toward both bacteriocins. It
does so, most likely, by removing the two polypeptides
from the cytoplasmic membrane. This is the first report
in which a multidrug transporter protein is shown to be
involved in both secretion and immunity of antimicro-
bial peptides.
Bacteriocins are ribosomally synthesized antimicrobial pep-
tides produced by a large variety of bacteria (1, 2). This group
of antibacterial compounds is also found in plants (e.g. thionins
(3)) and animals (e.g. defensins, magainins, and cecropins (4)).
The eukaryotic antimicrobials share a number of structural
similarities with bacterial bacteriocins such as a very small
size and considerable amphiphilicity.
Most bacteriocins produced by the Gram-positive lactic acid
bacteria (LAB)1 characterized to date are small (less than 6
kDa), cationic, and amphiphatic membrane permeabilizing
peptides (2). They can be classified into three main groups (5).
Group I comprises the lantibiotics that contain post-transla-
tionally modified amino acids, such as lanthionine and -meth-
yllanthionine and the dehydrated residues dehydroalanine and
dehydrobutyrine (6, 7). Group II, consisting of the unmodified
heat-stable peptide bacteriocins (the non-lantibiotics), can be
further divided into Group IIa, the pediocin-like bacteriocins (8,
9), Group IIb, the two-peptide bacteriocins, which require the
complementary action of two peptides for full antimicrobial
activity (10, 11), and Group IIc, other unmodified bacteriocins.
Group III contains larger and heat-labile bacteriocins. Bacte-
riocins are mainly synthesized as precursor peptides with an
N-terminal leader sequence (12). The primary translation prod-
uct of most non-lantibiotics and some lantibiotics contains a
leader peptide of the double glycine-type (Gly2-Gly1), which
is cleaved off during export across the cytoplasmic membrane
by dedicated ATP-binding cassette (ABC) transporters and
their accessory proteins (13, 14). Some bacteriocins, e.g. diver-
gicin A, enterocin P, and listeriocin 743A (9, 15), are exported
across the cytoplasmic membrane by the general secretory
pathway (16). They contain canonical sec signal peptides con-
sisting of a positively charged N terminus, a hydrophobic core,
and a defined cleavage site that is removed by a specific signal
peptidase during translocation. Some bacteriocins produced by
Enterococcus faecium, e.g. enterocin L50A and L50B, and en-
terocin Q have been shown recently (17, 18) to be synthesized
without an N-terminal leader sequence or signal peptide.
All bacteriocin producers are insensitive to the bacteriocin(s)
they produce. The genetic determinants proposed or confirmed
to confer immunity are frequently found downstream of the
bacteriocin structural gene(s) in the bacteriocin operon (2, 12).
These immunity proteins usually have a high pI, and those that
are associated with one-peptide bacteriocins are generally
small in size (51 to 113 amino acids) and contain no or only a
few (one to two) potential transmembrane helices (10, 12, 19).
Here, we report the characterization of two novel and highly
different bacteriocins, LsbA and LsbB, produced by Lactococcus
lactis. The cognate genes were cloned and sequenced, and their
transcription was analyzed. Also, the processing mechanism of
LsbA, the secretion of both bacteriocins, and the resistance
mechanism against both peptides were studied. Both secretion
and immunity were found to rely on the activity of a single
multidrug resistance (MDR) transporter protein.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Media
Bacterial strains and plasmids used in this study are listed in Table
I. L. lactis was grown at 30 °C in chemically defined medium CDM (20),
M17 (Difco; West Molesey, United Kingdom), or 1⁄2 M17 broth (contain-
ing 0.95% -glycerophosphate; Sigma) as standing cultures and on M17
agar plates containing 1.5 or 0.75% (w/v) agar. All media contained
0.5% (w/v) glucose, whereas 5 g/ml chloramphenicol (Sigma) or 5
g/ml erythromycin (Roche Applied Science) were added when needed.
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 31-50-3632111;
Fax: 31-50-3632348; E-mail: j.kok@biol.rug.nl.
1 The abbreviations used are: LAB, lactic acid bacteria; ABC, ATP-
binding cassette; MDR, multidrug resistance; GFP, green fluorescent
protein; PAA, polyacrylamide; RT, reverse-transcribed; ORF, open
reading frame.
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5-Bromo-4-chloro-3-indolyl--D-galactopyranoside (Sigma) was used at
a concentration of 1 mM.
DNA Techniques and Transformation
Molecular cloning techniques were performed essentially as de-
scribed by Sambrook et al. (21). Restriction enzymes, T4 DNA ligase,
and ExpandTM High Fidelity DNA polymerase (Roche Applied Science)
were used according to the instructions of the supplier. Synthetic oli-
gonucleotides were obtained from Invitrogen. The High Pure PCR prod-
uct purification kit (Roche Applied Science) was used to purify PCR
products. For nucleotide sequence analysis the dideoxy chain termina-
tion method (22) was used with [-35S]dATP and the T7 sequencing kit
(Amersham Biosciences). L. lactis was transformed by electroporation
using a gene pulser (Bio-Rad) as described by Leenhouts and Venema
(23). The DNA sequence of the pMN5 was deposited in GenBankTM
under the accession number AF056207.
Plasmid Construction
The lmrB gene was amplified from pMN5 by PCR with oligonucleo-
tides LMRB1 (5-TCTAGACCACCATGGGGCATCACCATCACCATCA-
CGATGACGATGACAAAGCCGAAAGAGG), introducing the under-
lined NcoI restriction enzyme site upstream of the His6 tag (italic), and
LMRB2 (5-ATATCTAGAGTTAATTGATTCTGAAC), introducing the
underlined XbaI restriction enzyme site downstream of the stop codon
(italic) of lmrB. The purified 1764-bp PCR product was digested with
NcoI and XbaI and ligated into the corresponding sites in pNZ8048,
resulting in pNHlmrB. The lsbB gene was amplified with oligonucleo-
tides LSBB-1 (5-CCGGTCATGAAAACAATCCTACG) and LSBB-2 (5-
CTGGTCTAGATTAAGCTTTTCCACG) by using pMN5 as a template.
An RcaI and XbaI (underlined) digested PCR product was ligated into
the NcoI and XbaI sites of pNZ8048, resulting in pNZlsbB. Oligonucleo-
tides LSBA-1 (5-CCGGTCATGATAATTGTAGGAATTATATTTTTG)
and LSBA-2 (5-CTGGTCTAGATTATGCATATCTTGGTAC) were used
to amplify lsbA gene from plasmid pMN5. The PCR product was di-
gested with RcaI and XbaI (underlined) and ligated into the NcoI and
XbaI sites of pNZ8048, resulting in pNZlsbA. To make an lmrB-lsbB
operon, lmrB was amplified by PCR using oligonucleotides LMRB3
(5-CCGGAGCTCTAAAAAGGAAGTGATAAATTTATG) and LMRB2.
SacI and XbaI (underlined) digested PCR product was ligated into the
corresponding sites in pNZlsbB, resulting in pNZlsbB-lmrB. To con-
struct an in-frame N-terminal fusion with the green fluorescent protein
(GFP), lmrB was amplified by PCR using LMRB4 (5-CCGGAAT-
TCATATGAAATTTTTGAAAGACAAATC) and LMRB2 as oligonucleo-
tides. The PCR product was digested with EcoRI and XbaI (underlined)
and ligated into the corresponding restriction enzymes sites of pGFP-
mut1, containing gfp-mut1 downstream of the nisA promoter (PnisA),
resulting in pNZgfp-lmrB. All plasmids were introduced in L. lactis
NZ9000 to enable nisin induction. Nisin induction of PnisA in the
pNZ8048 derivatives was performed as described by de Ruyter et al.
(24).
To investigate the transcription of lsbB and lmrB the DNA fragment
containing the expression signals of the divergently transcribed lsbB
and lmrB genes was amplified from pMN5 by PCR using oligonucleo-
tides P1 (5-CTCGTGATCATAGGTTTACTTCCTTTC) and P2 (5-CAG-
GTGATCATAAATTTATCACTTCC) containing BclI restriction sites
(underlined) that overlap the lsbB and lmrB initiation codons. BclI
digested PCR product was ligated into the BamHI site of pGKH10,
resulting in pGKH1 and pGKH2. In plasmid pGKH1, the lacZ gene is
under the control of the LsbB promoter, whereas the lmrB promoter
directs the transcription of the -galactosidase gene. The promoter
fragment is present in the reverse orientation in pGKH2.
Construction of an lmrA Deletion Strain
The non-autonomously replicating vector pORI280 (25) was used to
construct an lmrA replacement plasmid. The 1561-bp EcoRV fragment
encoding the N-terminal portion of LmrA was deleted from pAPL2.2 The
resulting plasmid pAPL3 was digested with ScaI and BamHI yielding a
2 K. Venema, unpublished data.
TABLE I
Bacterial strains and plasmids used in this study
Emr, Cmr, Apr, resistance to erythromycin, chloramphenicol, and ampicillin, respectively. PlsbB; lsbB promoter; PlmrB; lmrB promoter; PnisA, nisin
inducible nisA promoter; Gal, galactosidase.
Strain or plasmid Relevant phenotype or genotype Source or reference
L. lactis sp. cremoris
MG1363 Plasmid-free derivative of NCDO712; LmrA LmrP Ref. 47
MG1363lmrP MG1363 derivative with deletion in lmrP Ref. 39
NZ9000 MG1363 pepN::nisRK Ref. 35
NZ9700 Nisin producing transconjugant of MG1363 containing the nisin-sucrose transposon
Tn5276
Ref. 48
NZ9000lmrA MG1363 pepN::nisRK with deletion in lmrA This work
NZ9000acmA htrA MG1363 pepN::nisRK containing deletions in acmA and htrA Kees J. Leenhouts
LL108 MG1363 derivative carrying the pWV01 repA gene downstream of the promoter P23 in
its chromosome
Ref. 25
L. lactis sp. lactis
BGMN1–5 Wild type strain, Bac501, Bac513 Ref. 30
BGMN1–596 Plasmid-free derivative of BGMN1–5; Bac501, Bac513 Ref. 30
IL1403 Plasmid-free strain; LmrA, LmrP Ref. 49
JIM7049 IL1403 his::nisRK Ref. 50
pNZ8048 Cmr inducible expression vector carrying PnisA Ref. 35
pNHlmrA his6-lmrA of L. lactis MG1363 behind PnisA Ref. 51
pHLP5 his6-lmrP of L. lactis MG1363 behind PnisA Ref. 52
pORI280 Emr, ori of pWV01, replicates only in strains carrying repA in trans Ref. 25
pMN5 Plasmid carrying lmrB, lsbA, and lsbB Ref. 30
pNZlsbA Cmr, pNZ8048 carrying lsbA This work
pNZlsbB Cmr, pNZ8048 carrying lsbB This work
pNHlmrB Cmr, pNZ8048 containing his6-lmrB This work
pNZlsbB-lmrB Cmr, pNZlsbB derivative containing lmrB in an operon structure with lsbB This work
pNZlsbB-lmrA Cmr, pNZlsbB derivative containing lmrA in an operon structure with lsbB This work
pNZgfp-lmrB Cmr, pGFP-mutI derivative containing lmrB fused C-terminally to gfp This work
pGFP-mutl Cmr, pNZ8048 containing gfp mutI Nathalie Campo
pNZ9530 Emr, pIL252 derivative carrying nisRK Ref. 53
pVE6007 Cmr, Ts replication derivative of pWV01 Ref. 54
pAPL2 Apr, pUC19 carrying a 6063-bp lactococcal chromosomal DNA fragment with lmrA gene Koen Venema
pAPL3 Apr, pAPL2 with 1561-bp EcoRV deletion This work
pORIlmr pORI280 carrying 3.234-kb ScaI/BamHI fragment from pAPL3, containing lmrA
deletion and its flanking regions
This work
pGKH10 Emr, Cmr, contains promoterless genes for -Gal and -Gal (lacZ) Ref. 36
pGKH1 Emr, Cmr, contains genes for -Gal and -Gal controlled by PlmrB and PlsbB, respectively This work
pGKH2 Emr, Cmr, contains genes for -Gal and -Gal controlled by PlsbB and PlmrB, respectively This work
Lmr-mediated Bacteriocin Secretion and Immunity34292
 at University of G
roningen on M









3.234-kb fragment with the lmrA deletion and its flanking regions. This
fragment was ligated into corresponding sites in pORI280. The result-
ing plasmid, pORILmr, was used to transform L. lactis LL108, which
carries the repA gene on the chromosome, thereby allowing the
pORI280 derivative to replicate. pORILmr isolated from this strain was
introduced, together with pVE6007, into L. lactis NZ9000. As this
strain does not contain the repA gene, selection for growth in the
presence of erythromycin and increased temperature (37 °C) forces
pORILmr to integrate into the chromosome by homologous recombina-
tion. A number of integrants were subsequently grown for about 30
generations under non-selective conditions allowing a second recombi-
nation event to occur, which results in either the deletion or the wild-
type gene lmrA. The lmrA mutation was confirmed by PCR, as well as
Southern hybridization experiments.
Assay of -Galactosidase Activity
The activity of -galactosidase was measured during growth of
L. lactis in a 96-well microtiter plate (Greiner Bio-One B.V., Alphen,
The Netherlands) using the GENios microtiterplate reader and Ma-
gelan software (Tecan, Gro¨dig, Austria). -Galactosidase activity was
measured by conversion of T657 substrate (trifluoromethylumbelliferyl-
-D-galactopyranoside; Molecular Probes) into T659 fluorescent prod-
uct. Fluorescence was followed using excitation and emission wave-
lengths of 360 and 535 nm, respectively. Culture optical densities were
measured at 595 nm. Specific -galactosidase activity was calculated as
arbitrary fluorescence units divided per time and optical absorbance
(AFU  min1  A595
1).
Bacteriocin Activity Assays
Bacteriocin activity was detected using an agar-well diffusion assay
(1). To this end, wells made in the lawn of soft agar with an indicator
strain (106 cells/ml), which was poured onto agar plates, were filled with
50-l aliquots of supernatant. To detect bacteriocin activity on SDS-
polyacrylamide (PAA) gels, an overlay assay was used (26). The super-
natant of a nisin-induced culture of a bacteriocin producer (2 ml) was
concentrated 20-fold by phenol/ether extraction (27), after which 15 l
was loaded onto an SDS-20% (w/v) PAA gel. After electrophoresis the
gel was treated twice for 30 min with a mixture of isopropanol (20%)
and acetic acid (10%), washed with several changes of demineralized
water, and overlaid with soft agar containing 106 cells/ml of an indicator
strain, followed by overnight incubation at 30 °C.
Bacteriocin Purification and N-terminal Amino Acid
Sequence Determination
LsbA and LsbB were purified from 50 ml of nisin-induced cultures of
L. lactis NZ9000 carrying pNZlsbA or pNZlsbB, respectively. Cells were
removed by centrifugation, after which the supernatant was concen-
trated 20-fold by phenol/ether extraction (27). The supernatant was
dialyzed against several changes of demineralized water at 4 °C, using
cellulose ester membranes with a molecular mass cut-off of 1 kDa
(SpectraPor® CE; Spectrum Laboratories). Quantification of protein
was done by the Bradford method, using bovine serum albumin as a
standard. The purified sample was subjected to SDS 20% (w/v)-PAA gel
electrophoresis (28) using the Rainbow pre-stained low range molecular
weight protein marker (Amersham Biosciences) as a size reference. The
protein band corresponding to active bacteriocin was excised from a
Coomassie Brilliant Blue-stained SDS-PAA gel and destained for 1 h at
room temperature in a solution of 45% methanol, 10% acetic acid. The
purified protein was subjected to N-terminal amino acid sequencing
(Eurosequence, Groningen, The Netherlands) by means of Edman deg-
radation on an automated sequenator (model 477A; Applied Biosys-
tems) using protocols, chemicals, and materials from Applied Biosys-
tems (Foster City, CA).
RNA Analysis
Primer Extension Analysis—RNA was isolated from exponentially
growing L. lactis cells as described by van Asseldonk et al. (29). Syn-
thesis of cDNA was performed using SUPERSCRIPT transcriptase
(Invitrogen). mRNA (3.5 g) was reverse-transcribed using 25 ng of
synthetic oligonucleotide REP1 (5-AATTAAGATAGCCTAACTCC),
which anneals at the 5 of the repA, or LSBA (5-GTACAAAATAATGC-
TATAGC), which anneals at the 5 of lsbA, and dATP, dGTP, dTTP, and
[-P32]dCTP (Amersham Biosciences). Reaction mixtures were incu-
bated for 10 min at 42 °C, after which an excess in cold dCTP was
added, and incubation was continued for another 10 min at 42 °C. The
reaction products were separated by electrophoresis on a 6% polyacryl-
amide urea gel and analyzed by autoradiography.
RT-PCR—First strand cDNA synthesis with reverse transcriptase
was carried out with the first strand cDNA synthesis kit for RT-PCR
from Roche Applied Science. mRNA (2 g) was reverse-transcribed with
50 ng of synthetic oligonucleotide LMRB (5-CTATATTGATACCTT-
GAC). The cDNA thus obtained was subsequently amplified by PCR
using REP2 (5-GAAATTGGCAACAACG) in combination with REP3
(5-CCCAATTCCAAATCGC) or LSBA-3 (5-GTACAAAATAATGCTAT-
AGC). The size of the obtained PCR products was checked on a 1% (w/v)
agarose gel.
Northern Hybridization—RNA for Northern blot analysis was frac-
tionated on a 1% formaldehyde-agarose gel (21). The RNA size marker
(0.5–9 kb) was from Ambion (Austin, TX). Purified PCR products ob-
tained with the oligonucleotides LMRA1 (5-TGATTGGGATTGTG-
GCTGG) and LMRA2 (5-CAAAACCAATTTGACTCCGCC), containing
the 5 end of lmrA, or LMRP1 (5-CAATGATTTTTGGAAGTGGGC) and
LMRP2 (5-CTCATCAACTTTGACTGTGG), containing the 5 end of
lmrP, were used as probes. Labeling of probes and transcript detection
were performed with the ECL detection system (Amersham Bio-
sciences) according to the manufacturer’s instructions.
RESULTS
Sequence Analysis of the Locus Responsible for Bacteriocin
Production in L. lactis BGMN1–5—L. lactis sp. lactis
BGMN1–5 has been shown previously (30) to produce two class
II bacteriocins, Bac513 and Bac501. By means of plasmid cur-
ing, derivatives of L. lactis BGMN1–5 have been obtained that
lack one or more of the five resident plasmids. Bac513 has been
shown to be only produced when a 5.65-kb plasmid (pMN5) was
present. The genetic information for the production of Bac501
is located on a 80-kb plasmid (30) and will not be discussed
further. Subcloning of the two EcoRI fragments of pMN5 re-
vealed that the genetic information for the production of and
immunity toward Bac513 is located on the 3.28-kb EcoRI frag-
ment of pMN5 (Fig. 1A). Three open reading frames (ORFs)
could be discerned in the nucleotide sequence of this region
(Fig. 1C). The first ORF could encode a peptide of 67 amino acid
residues with a calculated molecular mass of 7.8 kDa. The ATG
start codon is preceded by a potential ribosome binding site
(GAGGA), but no obvious 35 and 10 consensus promoter
regions were present. Two 12-bp inverted repeats separated by
four nucleotides are present immediately downstream of this
ORF, which could form a stable stem-loop structure with an
estimated G° of 15.2 kcal/mol (63.6 kJ/mol) and could
serve as a bidirectional rho-independent transcription termi-
nator (31). The divergently oriented ORF could specify a 30-
amino acid peptide with a calculated molecular mass of 3.4
kDa. The gene is preceded by a strong potential ribosome
binding site (AGAAAGGAAG). The third ORF could encode a
protein of 567 amino acid residues with a calculated molecular
mass of 63.8 kDa. This ORF is preceded by a potential ribosome
binding site (AAAGGAAG) and is located immediately down-
stream of the oppositely oriented second ORF. A 96-bp inter-
genic region separates both genes.
The deduced amino acid sequences of the two small ORFs do
not share mutual similarity nor do they show homology with
any entry in the protein databases. The product of the large
ORF shares 34% sequence identity with the multidrug trans-
porter protein LmrA of L. lactis MG1363 (32) and, like LmrA,
is a half-size version of the human multidrug resistance P-
glycoprotein (33). Based on this homology the gene was labeled
lmrB. LmrB is homologous to many pro- and eukaryotic
ABC transporters and to the hop resistance protein HorA of
the beer-spoilage bacterium Lactobacillus brevis (34). Strain
L. lactis BGMN1–5 contains neither lmrA nor lmrB on its
chromosome.
Bac513 Activity Is a Mixture of Two Bacteriocins—The L. lac-
tis BGMN1–5 plasmid pMN5 has been shown to specify bacte-
riocin activity, which has been named Bac513 (30). To investi-
gate which of the two small ORFs carried by the 3.28-kb EcoRI
fragment of pMN5 encodes Bac513 activity, the ORFs were
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cloned separately in a lactococcal expression vector, down-
stream of the nisin-inducible promoter PnisA (35). The two
plasmids pNZlsbA and pNZlsbB, carrying the 67- and the 30-
codon ORFs, respectively, were introduced in the naturally
resistant L. lactis strain NZ9000. This L. lactis MG1363 deriv-
ative contains the nisRK genes needed for inducible expression
of both ORFs from PnisA (35). Moreover, this strain specifies
LmrA, which, as we will show below, is needed for LsbA and
LsbB secretion. The supernatants of both strains were shown
to inhibit the growth of L. lactis sp. lactis IL1403, a strain that
does not produce LmrA or LmrP, indicating that the gene
products of both ORFs are secreted and have antimicrobial
activity. The two peptides do not act synergistically, because
the titer of a mixture of both was the same as the sum of the
individual titers. Hereafter, the gene products are designated
LsbA and LsbB for the 67- and the 30-residue peptides,
respectively.
Neither LsbA nor LsbB inhibits the growth of strains of the
FIG. 1. A, linear map of pMN5. Positions and orientation of genes are indicated by the block arrows, promoters are indicated by vertical arrows,
and putative terminator structures are indicated by ball-and-stick symbols. The DNA fragment of which the sequence is presented in C is boxed.
B, analysis of transcription of lsbA. The products obtained by PCR amplification of RT-mRNA using the oligonucleotides located within repA (lane
2) and at the 5-end of repA and within lsbA (lane 4). PCR amplification of the control samples without RT reaction is shown in lanes 1 and 3. The
sizes of the products are indicated in the right margin. In the left panel the location of the PCR products on the map in panel A is shown. C,
nucleotide sequence of a 530-bp DNA fragment from pMN5 containing the structural genes of LsbA and LsbB and the start of lmrB. The deduced
amino acid sequences are shown below the DNA sequence. Putative ribosomal binding sites (RBS) and 35 and 10 promoter sequences are
overlined. Start codons are indicated in bold. The horizontal arrows indicate a potential rho-independent transcription terminator sequence. A
vertical arrow indicates the cleavage site in pre-LsbA.
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Gram-positive species Lactobacillus, Leuconostoc, Bacillus,
Enterococcus, and Staphylococcus or that of several Gram-
negative bacteria tested (Escherichia coli C600, Salmonella
thyphimurium LT2, Pseudomonas sp.). In fact, only closely
related L. lactis strains are inhibited, showing that both bac-
teriocins exhibit a very narrow antibacterial spectrum.
Analysis of Transcription of the Bacteriocin Encoding
Genes—No consensus promoter sequence is present immedi-
ately upstream of lsbA. In accordance with this observation, no
transcription initiation start site could be determined by
primer extension mapping. A promoter sequence (P1) is present
upstream of the preceding gene, that of the plasmid replication
protein RepA (Fig. 1A). Primer extension analysis confirmed
the position of this postulated promoter, 80 nt upstream of the
repA start codon (data not shown). RT-PCR on total RNA
isolated from L. lactis (pMN5) with a primer located within
lsbA and one immediately upstream of repA gave a product of
the expected size (1457 bp; see Fig. 1B). An equal amount of
total RNA sample was amplified with the same primers with-
out a prior RT-PCR to confirm that no contaminating DNA
material was present. These data indicate that lsbA and repA
are located in one operon and form a transcriptional unit.
The region between lsbB and lmrB contains two putative
promoters, P2 and P3 (Fig. 1A). Gene lsbB is preceded by
possible35 (ATCACA) and10 (TATTAT) sequences that are
17 nucleotides apart. The 35 and 10 promoter sequences
upstream of lmrB (TTAGAA and AATAAT, respectively, with a
spacing of 16 nucleotides), could constitute promoter P3 (Fig.
1C). A DNA fragment carrying the expression signals of the
divergently transcribed lsbB and lmrB genes was inserted, in
two orientations, between the two promoterless reporter genes
in pGKH10 in such a way that translational fusions were
created. The reporter genes in pGKH10 encode E. coli -galac-
tosidase and Cyamopsis tetragonoloba -galactosidase (36).
The lmrB and lsbB genes were mainly expressed during the
exponential growth phase (Fig. 2). By comparing -galactosid-
ase activity levels it was shown that the expression signals of
lsbB are about 2.5-fold stronger than those of lmrB. Taken
together these results show that lsbB and lmrB are both ac-
tively transcribed.
LsbA Is Processed by HtrA—LsbA and LsbB were purified
from the supernatant of L. lactis NZ9000 containing either
pNZlsbA or pNZlsbB, respectively, and the purified peptides
were subjected to N-terminal amino acid sequencing. The mo-
lecular mass of the secreted form of LsbA, estimated after
SDS-20% PAGE, was 3 kDa (Fig. 3), indicating that LsbA is
synthesized as a pre-protein. The first five amino acids ob-
tained by Edman degradation were Phe-Lys-Lys-Lys-Lys, indi-
cating that the bacteriocin is processed between the two puta-
tive membrane spanning domains, leaving a highly positive
charge on the N terminus of the mature protein (Fig. 1C). No
consensus signal peptidase I or II cleavage site is present in the
deduced amino acid sequence of LsbA. Instead, the region of
cleavage shows similarity with the cleavage site of the house-
keeping protease HtrA (37). The production of LsbA was exam-
ined in a lactococcal strain in which the chromosomally located
htrA gene was inactivated by single cross-over homologous
recombination. As can be seen in Fig. 4A, no active LsbA was
present in the supernatant. Moreover, in a total cell extract of
L. lactis NZ9000acmAhtrA, LsbA was detected as an inac-
tive pre-bacteriocin by SDS-20% PAGE (Fig. 4B). The super-
natant of this strain contained neither pre-LsbA nor the ma-
ture bacteriocin. By contrast, processed LsbA was detected in
the supernatant of a wild-type strain (Fig. 4B). These data
clearly show the involvement of HtrA in LsbA processing dur-
ing or immediately after translocation of pre-LsbA across the
cytoplasmic membrane.
The amino acid sequence Met-Lys-Thr-Ile-Leu-Arg-Phe-Val-
Ala-Gly was obtained after Edman degradation of purified
LsbB. Apparently, the product of lsbB is secreted without N-
terminal processing (Fig. 1C).
LmrB Renders Cells Resistant to LsbA and LsbB—Hydropa-
thy analysis of LmrB suggests the presence in the N terminus
of six putative -helical transmembrane segments and a C-
terminal, highly conserved hydrophilic nucleotide binding do-
main. This latter domain contains features diagnostic for ABC-
type ATPases, such as the ABC signature sequence and the
Walker A and B motifs (38). LmrB was shown to be an active
MDR transporter protein involved in the extrusion from the
cytoplasmic membrane of the typical MDR protein substrates
ethidium bromide and the amphiphilic compound Hoechst
33342.3 To visualize the protein in situ, LmrB was N-termi-
nally fused to GFP and overexpressed from the nisin inducible
PnisA promoter. After nisin induction the GFP:LmrB fusion
protein was shown to be distributed all along the cytoplasmic
3 O. Gajic, G. Buist, A. Margolles, W. N. Konings, L. Topisirovic, J.
Kok, and O. P. Kuipers, unpublished data.
FIG. 2. Analysis of transcription of lsbB:lacZ (in pGKH1) and
lmrB:lacZ (in pGKH2) transcriptional fusions. Specific -galacto-
sidase activity of L. lactis MG1363 carrying pGKH1 (Œ) or pGKH2 ()
during growth in GM17 containing the fluorescent -galactosidase sub-
strate trifluoromethylumbelliferyl--D-galactopyranoside is shown. Op-
tical density of MG1363 (pGKH1) (‚) and MG1363 (pGKH2) (E) was
measured at 595 nm. The excitation and emission wavelengths of trif-
luoromethylumbelliferyl--D-galactopyranoside were 355 and 457 nm,
respectively. Specific -galactosidase activity was calculated as arbi-
trary fluorescence units divided per time and optical absorbance
(AFU  min1  A595
1).
FIG. 3. Detection of purified LsbA and LsbB and their activi-
ties in an SDS 20% polyacrylamide gel. A, Coomassie Brilliant Blue
staining. B, bacteriocin activity as visualized by an activity overlay
assay using L. lactis IL1403 as the indicator strain. 15 l of a 10-fold
concentrated supernatant of a nisin-induced culture of L. lactis NZ9000
(pNZlsbA) (lanes 1) or L. lactis NZ9000 (pNZlsbB) (lanes 2) were ap-
plied. Molecular masses (in kDa) of reference proteins are shown on the
left.
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membrane by fluorescence microscopy (Fig. 5A). In contrast,
when expressed alone, GFP was present in the cytoplasm
(Fig. 5B).
To examine the possible involvement of LmrB in immunity
against LsbA and LsbB, a histidine (His6)-tagged variant of the
protein was overexpressed in L. lactis by using the nisin con-
trolled gene expression system (35). His6-LmrB was of the ex-
pected molecular size (65.4 kDa) in Western blotting using mono-
clonal antibodies directed against the histidine tag (data not
shown). L. lactis strain IL1403 is very sensitive for LsbA and
LsbB. A derivative of this strain, L. lactis JIM7049, containing
the nisRK genes needed for nisin induction of PnisA was used as
the host for His6-LmrB expression. L. lactis JIM7049 (pNHlmrB)
became resistant to both LsbA and LsbB when His6-LmrB
expression was induced with nisin. Moreover, expression in
L. lactis JIM7049 of two other lactococcal multidrug transporter
proteins, LmrA and LmrP (32, 39), also resulted in resistance
against both bacteriocins to the same level as L. lactis MG1363
(data not shown). These findings demonstrate that resistance to
LsbA and LsbB can be accomplished via all three MDR proteins.
LmrA and LmrP Are Not Expressed in L. lactis IL1403—In
contrast to L. lactis IL1403, the growth of L. lactis sp. cremoris
NCDO712 or its plasmid-free derivative MG1363 is not inhib-
ited by LsbA and LsbB. Strain MG1363 produces both MDR
proteins, LmrA and LmrP (32, 39). The lmrA gene is also
present in the chromosome of L. lactis IL1403 (40), but it is
preceded by a nucleotide sequence that is different from that of
the region preceding lmrA in MG1363. The gene in strain
IL1403 is preceded by a potential ribosome binding site (AAAG-
GAAG), but no obvious 35 and 10 consensus promoter re-
gions could be discerned. Possibly, lmrA is in an operon with
the upstream-located yhbF, encoding a hypothetical protein.
However, two 14-bp inverted repeats separated by 15 nucleo-
tides are present immediately upstream of the RBS and could
form a stable stem-loop structure with an estimated G° of
14.9 kcal/mol (62.3 kJ/mol). This structure could serve as a
rho-independent transcription terminator blocking transcrip-
tion of lmrA. Also, the 35 and 10 consensus promoter re-
gions of the lmrP genes of L. lactis strains MG1363 and IL1403
are different. In MG1363, lmrP is preceded by possible 35
(TTGACT) and 10 (TATAAA) sequences with a spacing of 16
nucleotides (39). The putative 35 and 10 promoter se-
quences upstream of lmrP in strain IL1403 (TTGCAG and
TTTAAA, respectively) most likely do not constitute an active
promoter. Immediately downstream of both lmrPs, the oppo-
sitely oriented sipX is located.
Northern analysis of the lmr genes in both strains after
hybridization with an lmrA-specific probe revealed a transcript
of 1.8 kb only in RNA isolated from MG1363. A transcript of 1.3
kb was observed with the same RNA when an lmrP-specific
probe was used. No transcripts were detected in RNA isolated
from strain IL1403 with either of the two probes (Fig. 6). These
findings demonstrate that, although lmrA and lmrP are pres-
ent on the chromosome of IL1403, they are not transcribed.
LmrB Is Involved in Bacteriocin Secretion—The secretion of
both bacteriocins by L. lactis was not affected by the addition of
2 mM azide, a known inhibitor of the Sec translocation pathway
in B. subtilis (41), to the growth medium (data not shown).
Next, we examined whether LmrB mediates the secretion of
both bacteriocins. To this end, His6-LmrB was overexpressed in
either lmrA- or lmrP-deficient isogenic L. lactis MG1363 deriv-
atives. The experiments could not be done in an lmrA, lmrP
double mutant as such a strain is, apparently, not viable. Lack
of active LmrP did not have any effect on the secretion of LsbB
(Fig. 7). In contrast, no secretion of LsbB was observed in
L. lactis NZ9000lmrA. Upon disruption of the cells, active
LsbB was shown to be present intracellularly by an SDS-PAA
gel overlay assay (data not shown). The function of LmrA could
be complemented either by LmrB or by LmrA, as was shown by
the introduction of pNZlsbB-lmrB or pNZlsbB-lmrA in
NZ9000lmrA; nisin-induced co-expression of LsbB with LmrA
or LmrB from these plasmids resulted in the secretion of active
LsbB (Fig. 7). The same observations were made with respect
to the secretion of LsbA (data not shown). Taken together these
findings show that the multidrug transporter proteins LmrA
and LmrB are directly involved in the secretion of LsbA and
LsbB, whereas LmrP is not.
FIG. 4. LsbA production in L. lactis strains NZ9000 and
NZ9000acmAhtrA. A, detection of LsbA activity using an agar-well
diffusion assay. The indicator strain used was L. lactis IL1403. B,
detection of LsbA in an SDS 20% polyacrylamide gel stained with
Coomassie Brilliant Blue. Lane 1, 10-fold concentrated supernatant of a
nisin-induced culture of L. lactis NZ9000 (pNZlsbA); lanes 2 and 3, total
cell extract and 10-fold-concentrated supernatant of L. lactis
NZ9000acmAhtrA (pNZlsbA), respectively. Molecular masses (in
kDa) of reference proteins are shown on the left.
FIG. 5. Fluorescence microscopy analysis of L. lactis NZ9000
cells expressing GFP:LmrB fusion protein (A) or GFP (B). Fluo-
rescence was visualized using a Zeiss Axiophot (Zeiss) microscope and
an Axion Vision camera (Axion Technologies, Houston, TX).
FIG. 6. Northern analysis of lmrA and lmrP transcription. Total
RNA (5 g) isolated from L. lactis MG1363 (lane 1) or L. lactis IL1403
(lane 2) was hybridized with an lmrA-specific probe (A) or an lmrP-
specific probe (B).
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The data presented here show that L. lactis BGMN1–5 pro-
duces three bacteriocins. The antimicrobial activity that had
previously been labeled Bac513 (30) is, in fact, the result of the
concerted action of two distinct bacteriocins, LsbA and LsbB.
Although LsbB is smaller than LsbA (30 instead of 44 amino
acid residues) and possesses less pronounced cationic and hy-
drophobic properties, both bacteriocins share the characteristic
physico-chemical properties of LAB bacteriocins (size, molecu-
lar weight, isoelectric point, and hydrophobicity) (2). They are
not post-translationally modified, because problems typically
encountered when determining the amino acid sequence of
proteins containing residues such as didehydroalanine, dide-
hydrobutyrine, lanthionine, and -methyllanthionine (6, 7)
were not observed. Both peptides contain a stretch of four to
five positively charged amino acid residues. These are located
at the N terminus of LsbA and in the middle of LsbB. LsbA and
LsbB are apparently one-peptide bacteriocins, because each is
active on its own, and no additional bacteriocin encoding genes
could be discerned on pMN5. Based on the features described
above LsbA and LsbB can be regarded as members of LAB
bacteriocin group IIc.
Most bacteriocins are synthesized as precursor peptides con-
taining an N-terminal leader peptide with two conserved gly-
cine residues at positions 1 and 2 relative to the cleavage
site (14). Translocation across the cytoplasmic membrane and
the subsequent removal of the leader peptide during matura-
tion is carried out by a dedicated ABC transporter (14, 42, 43).
Only a few LAB bacteriocins described to date contain a typical
signal peptidase cleavage site (44) and are secreted by the
general secretory pathway (9, 15, 16, 45). Comparing the amino
acid sequence of purified LsbA with the deduced amino acid
sequence revealed that the bacteriocin is first produced as a
precursor peptide. Instead of a leader peptide of the double
glycine-type (14) or a consensus signal peptidase cleavage site
(44) a possible HtrA cleavage site could be discerned in pre-
LsbA (37). HtrA is a surface housekeeping protease in L. lactis
that was shown to have a dual function; it acts as a chaperone
and as a protease. It is responsible for both the degradation and
maturation of exported proteins (46). The activation of LsbA by
HtrA during or immediately after translocation of the bacteri-
ocin across the cellular membrane is a mechanism of process-
ing that is distinctly different from that of all other known
bacteriocins (14, 44).
For most non-lantibiotics, the gene encoding bacteriocin im-
munity is usually located immediately downstream of and in
the same operon as the bacteriocin structural gene(s) (2, 12).
LsbA and LsbB are exceptions to this rule. The gene conferring
immunity, lmrB, is located immediately downstream of and in
the opposite orientation to lsbB. LmrB is a member of the ABC
protein superfamily. It is homologous to LmrA of L. lactis
MG1363 (32), to prokaryotic ABC transporters of B. subtilis,
Staphylococcus aureus, E. coli, Campylobacter jejuni, and Hae-
mophilus influenzae and to the hop resistance protein HorA of
the beer-spoilage bacterium Lactobacillus brevis (34). LmrB is
also homologous to eukaryotic ABC transporters, e.g. human
multidrug resistance P-glycoprotein (33). LmrB and the other
two MDR proteins of L. lactis, LmrA and LmrP, were shown
here to confer immunity to LsbA and LsbB. In contrast to LmrB
and LmrA, LmrP is a proton motive force-driven transporter
(39). These three MDR proteins do not render cells resistant to
other lactococcal bacteriocins e.g. lactococcins A, B, M/N, or
nisin; they are rather specific for LsbA and LsbB.
It is not clear what the exact mechanism(s) are by which
immunity proteins function. Those predicted to have trans-
membrane helices, e.g. LciA, are envisaged to interact with and
block the receptor for the bacteriocin. By binding to the recep-
tor, LciA prevents lactococcin A from inserting into the mem-
brane, although binding of lactococcin A to the receptor still
occurs (19). Bacterial strains that produce multiple bacterio-
cins also produce different bacteriocin-specific immunity pro-
teins (11, 12). Here, we report that immunity against two
distinct bacteriocins relies on the activity of only one protein; in
the case of LsbA and LsbB, the protein that is responsible for
immunity is a multidrug transporter protein. The common
feature of most MDR proteins is their ability to extrude a wide
range of hydrophobic and amphiphilic compounds from the
cytoplasmic membrane (33). As both bacteriocins are hydropho-
bic molecules, it seems likely that all three lactococcal multi-
drug transporters mediate bacteriocin resistance by removing
bacteriocin that enters the cytoplasmic membrane from the
outside. Besides conferring immunity, we show that LmrB and
LmrA also function as exit pumps for the two bacteriocins,
extruding the molecules from their site of production, the cy-
toplasm, to the extracellular medium. Although LsbA is
cleaved during this process by HtrA, precursor cleavage per se
is not necessary for transport via LmrA or LmrB. LmrP clearly
is not involved in bacteriocin secretion and seems to be only
capable of removing the bacteriocins from (the outer leaflet of)
the cytoplasmic membrane, resulting in bacteriocin resistance.
Bacteriocin secretion via MDR proteins is a route of secretion
that is different from that of all other known bacteriocins and
also suggests a novel function of MDR proteins, namely the
secretion (extrusion) of natural biologically active peptides.
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